All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe

In the Spotlight Editor's Picks

September 2, 2010
Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2010
Volume 34
Issue 9

Editors' picks of pharmaceutical science and technology innovations.

The aim of any pharmaceutical production line is to create high-quality products within certain specifications. Manufacturing equipment is designed with this goal in mind, but some devices perform additional tasks as well. This month's products illustrate how production equipment and information technology can protect personnel and patients in addition to manufacturing medicines. Continental Disc designed one of its rupture discs to provide workers with extra protection against overpressure conditions. Spiroflow offers a bulk-bag discharger that could help patients by preventing cross-contamination. Software from Oracle is intended to secure the supply chain and reduce the opportunity for diversion.

Rupture disc offers durability

The SANITRX HPX scored, reverse-acting rupture disc from Continental Disc (Liberty, MO) protects equipment, vessels, and personnel from overpressure conditions. Precise forming and scoring of the rupture disc's dome enables the SANITRX HPX product to withstand hundreds of thousands of pressure cycles from full vacuum to 95% of the stamped burst rating. A failure-initiating indentation near the apex of the disc's dome lowers the pressure at which reversal occurs, compared with other failure-initiating methods, and enables the disc to be made of sturdy materials that are less susceptible to damage, fatigue, and corrosion. The product's durability makes it suitable for use on steam sterilizers and purified-water systems.

The rupture disc is available with a 95% operating ratio and zero manufacturing range for high accuracy. A model with a 90% operating ratio and zero, –5%, or –10% manufacturing range is available for less demanding applications. The products are manufactured in various sizes with several materials, burst ratings, and gasket options.

SANITRX HPX rupture disc Continental Disc, www.contdisc.com

Software provides integrated serialization solution

Oracle (Redwood Shores, CA) designed its Pedigree and Serialization Manager to improve supply-chain integrity in the pharmaceutical industry. The system generates and stores serial numbers in compliance with international standards and allows companies to serialize products to the item level. The software tracks items as they are packaged and shipped, and generates a pedigree document to reflect the transactions. Thus, the application delivers clear visibility of the supply-chain areas through which the product has passed. In addition, the software's analytical dashboards enable personnel to monitor activities, transaction histories, and exceptions.

Pedigree and Serialization Manager Oracle, www.oracle.com

Discharger facilitates thorough cleaning

The Model T11 Bulk Bag Super Discharger from Spiroflow Systems (Monroe, NC) can be disassembled by two employees without tools and without the involvement of an engineer. The company created the discharger without pockets that could entrap dirt and dust. The unit's design thus facilitates thorough cleaning and helps prevent microbiological growth and cross-contamination.

The product's discharger frame comprises Z sections folded from stainless-steel sheet material. The smooth frame features easily cleaned radii and is available in bead-blast and mirror-polished finishes.

Model T11 Bulk Bag Super Discharger Spiroflow Systems, www.spiroflowsystems.com

The device's bag-lifting frame holds bags in place during discharge. Bag support arms are spring-loaded to stretch the bag and ensure the complete discharge of contents. In addition, a dust cabinet contains all ingredients during discharge. The bulk-bag neck is clamped to the inlet of the transfer hopper within the dust cabinet by a pharmaceutical quality, dust-tight seal that can be removed, cleaned, reassembled, and replaced.

Articles in this issue

i3_t-685638-1408626168354.jpg
In the Spotlight Editor's Picks
26_t-685644-1408626154740.jpg
FDA Struggles with Risk Management and Drug Safety
Q&A with Diteba's Theo Kapanadze
Q&A with Diteba's Theo Kapanadze
i8_t-686225-1408625780601.jpg
Strategic Approaches to Process Optimization and Scale-up
i1-685642-1408626159036.jpg
Above and Beyond
Report from Brazil September 2010
Report from Brazil September 2010
i1-685640-1408626163280.jpg
Congress Attempts to Fix a System that Isn't Broken
i4-685648-1408626141450.jpg
Technical Forum: Small-Molecule Synthesis
i1-685639-1408626165466.jpg
No More Exceptions
Going Digital
Going Digital
i1-685643-1408626156928.jpg
Statistical Solutions: Visual Inspection Goes Viral
Authentication and Pharmaceutical Protection: An Industry Roundtable
Authentication and Pharmaceutical Protection: An Industry Roundtable
i1-685887-1408626018875.jpg
Inside USP: Modernizing the Compendia
i1-685646-1408626148473.jpg
Survey Says...
Statistical Considerations in Design Space Development (Part III of III)
Statistical Considerations in Design Space Development (Part III of III)
Recent Videos
Behind the Headlines, Episode 17
Related Content

Gold winners award with three stars | Image Credit: © sergign - stock.adobe.com

ISPE Announces Six 2025 FOYA Category Winners

Patrick Lavery
May 15th 2025
Article

Six winners and two honorable mentions were revealed at ISPE’s Europe Annual Conference in London.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Piramal Pharma to Invest $90 Million at Kentucky & Michigan Sites

Patrick Lavery
May 12th 2025
Article

The company said the investment is in response not only to customer demand and a belief in the value of US-based innovation, but also because of the trend toward US onshoring brought about by new tariff policies.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Image Credit: © Alessandro Grandini - stock.adobe.com

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan
May 7th 2025
Article

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.


n-nitrosodimethylamine molecular structure, 3d model molecule, n-nitrosamines, structural chemical formula view from a microscope | Image Credit: © Сергей Шиманович - stock.adobe.com

Strategies for Mitigating Nitrosamine Risk

Susan Haigney
May 7th 2025
Article

Amit Chivate, senior market manager, Greater Asia and China, Roquette, provides his perspective on FDA’s recommendations regarding nitrosamines.

Related Content

Gold winners award with three stars | Image Credit: © sergign - stock.adobe.com

ISPE Announces Six 2025 FOYA Category Winners

Patrick Lavery
May 15th 2025
Article

Six winners and two honorable mentions were revealed at ISPE’s Europe Annual Conference in London.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Piramal Pharma to Invest $90 Million at Kentucky & Michigan Sites

Patrick Lavery
May 12th 2025
Article

The company said the investment is in response not only to customer demand and a belief in the value of US-based innovation, but also because of the trend toward US onshoring brought about by new tariff policies.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Image Credit: © Alessandro Grandini - stock.adobe.com

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan
May 7th 2025
Article

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.


n-nitrosodimethylamine molecular structure, 3d model molecule, n-nitrosamines, structural chemical formula view from a microscope | Image Credit: © Сергей Шиманович - stock.adobe.com

Strategies for Mitigating Nitrosamine Risk

Susan Haigney
May 7th 2025
Article

Amit Chivate, senior market manager, Greater Asia and China, Roquette, provides his perspective on FDA’s recommendations regarding nitrosamines.

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.